Buprenorphine + Naloxone Sublingual Films/Tablets Suppliers & Bulk Manufacturers

Available Forms: Sublingual Films/Tablets

Available Strengths: 2 mg buprenorphine / 0.5 mg naloxone, 8 mg / 2 mg

Reference Brands: Suboxone(US)

Category: Addiction Medicine / Substance Use

Buprenorphine + Naloxone sublingual films/tablets activate mu-opioid receptors, relieving pain and preventing withdrawal. Naloxone blocks opioid effects if injected, reducing misuse. Benefits include effective pain relief, lower overdose risk when used properly, and convenience of sublingual administration, promoting adherence and safety in opioid dependence and pain management.

Product Description:

Buprenorphine + Naloxone sublingual films and tablets are approved in the EU and US primarily for opioid dependence treatment, with some off-label use for pain. In the US, brands like Suboxone are regulated by the FDA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the EU, approval by EMA involves comprehensive dossiers, clinical data, and pharmacovigilance plans. Due to abuse potential, strict prescribing controls and monitoring are enforced. We support efficient market access for buprenorphine + naloxone formulations, ensuring adherence to European and US standards for safe, effective opioid dependence management and pain therapy.

Controlled medicine — licensed supply only

This product is controlled in many countries under narcotic, psychotropic, precursor or other drug laws, which vary by country. We supply only licensed buyers holding any import certificate, permit or authorisation their national authority requires, and the Indian manufacturer or exporter must hold the required licences. In India, each export of a narcotic drug or psychotropic substance needs an export authorisation, and export of ephedrine, pseudoephedrine or their preparations a No Objection Certificate, from the Narcotics Commissioner (Central Bureau of Narcotics). We verify permits before quoting.